Imperial College London

ProfessorDavidBrooks

Faculty of MedicineDepartment of Brain Sciences

Visiting Professor
 
 
 
//

Contact

 

david.brooks

 
 
//

Assistant

 

Ms Hyacinth Henry +44 (0)20 3313 3172

 
//

Location

 

U106Block B Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Publication Type
Year
to

928 results found

Madsen LS, Parbo P, Ismail R, Gottrup H, Ostergaard L, Brooks DJ, Eskildsen SFet al., 2023, Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease, NEUROBIOLOGY OF AGING, Vol: 123, Pages: 1-9, ISSN: 0197-4580

Journal article

Leng F, Hinz R, Gentleman S, Hampshire A, Dani M, Brooks DJ, Edison Pet al., 2022, Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease, MOLECULAR PSYCHIATRY, ISSN: 1359-4184

Journal article

O'Brien JT, Chouliaras L, Sultana J, Taylor J-P, Ballard Cet al., 2022, RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus, ALZHEIMERS RESEARCH & THERAPY, Vol: 14

Journal article

Horsager J, Okkels N, Fedorova TD, Knudsen K, Skjaerbaek C, Berge NVD, Jacobsen J, Munk OL, Danielsen EH, Bender D, Brooks DJ, Borghammer Pet al., 2022, [18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease, PARKINSONISM & RELATED DISORDERS, Vol: 104, Pages: 21-25, ISSN: 1353-8020

Journal article

Andersen OM, Bogh N, Landau AM, Ploen GG, Jensen AMG, Monti G, Ulhoi BP, Nyengaard JR, Jacobsen KR, Jorgensen MM, Holm IE, Kristensen ML, Alstrup AKO, Hansen ESS, Teunissen CE, Breidenbach L, Droescher M, Liu Y, Pedersen HS, Callesen H, Luo Y, Bolund L, Brooks DJ, Laustsen C, Small SA, Mikkelsen LF, Sorensen CBet al., 2022, A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency, CELL REPORTS MEDICINE, Vol: 3, ISSN: 2666-3791

Journal article

Venkataraman A, Mansur A, Rizzo G, Bishop C, Lewis Y, Kocagoncu E, Lingford-Hughes A, Huiban M, Passchier J, Rowe J, Tsukada H, Brooks D, Martarello L, Comley R, Chen L, Schwarz A, Hargreaves R, Gunn R, Rabiner E, Matthews Pet al., 2022, Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s Disease, Science Translational Medicine, Vol: 14, Pages: 1-11, ISSN: 1946-6234

Cell stress and impaired oxidative phosphorylation are central to mechanisms of synaptic loss and neurodegeneration in the cellular pathology of Alzheimer’s disease (AD). In this study, we quantified the in vivo expression of the endoplasmic reticulum stress marker, sigma 1 receptor (S1R), using [11C]SA4503 PET, the mitochondrial complex I (MC1) with [18F]BCPP-EF and the pre-synaptic vesicular protein SV2A with [11C]UCB-J in 12 patients with early AD and in 16 cognitively normal controls. We integrated these molecular measures with assessments of regional brain volumes and cerebral blood flow (CBF) measured with magnetic resonance imaging (MRI) arterial spin labelling. Eight patients with AD were followed longitudinally to estimate the rate of change of the physiological and structural pathology markers with disease progression. The patients showed widespread increases in S1R (≤ 27%) and regional reduction in MC1 (≥ -28%) and SV2A (≥ -25%) radioligand binding, brain volume (≥ -23%), and CBF (≥ -26%). [18F]BCPP-EF PET MC1 binding (≥ -12%) and brain volumes (≥ -5%) showed progressive reductions over 12-18 months, suggesting that they both could be used as pharmacodynamic indicators in early-stage therapeutics trials. Associations of reduced MC1 and SV2A and increased S1R radioligand binding with reduced cognitive performance in AD, although exploratory, suggested a loss of metabolic functional reserve with disease. Our study thus provides in vivo evidence for widespread, clinically relevant cellular stress and bioenergetic abnormalities in early AD.

Journal article

Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Haeberlein SB, Dam Tet al., 2022, Trial of Cinpanemab in Early Parkinson's Disease, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 387, Pages: 408-420, ISSN: 0028-4793

Journal article

Andersen KB, Hansen AK, Knudsen K, Schacht AC, Damholdt MF, Brooks DJ, Borghammer Pet al., 2022, Healthy brain aging assessed with [F-18]FDG and [C-11]UCB-J PET, NUCLEAR MEDICINE AND BIOLOGY, Vol: 112-113, Pages: 52-58, ISSN: 0969-8051

Journal article

Lillethorup TP, Noer O, Alstrup AKO, Real CC, Stokholm K, Thomsen MB, Zaer H, Orlowski D, Mikkelsen TW, Glud AN, Nielsen EHT, Schacht AC, Winterdahl M, Brooks DJ, Sorensen JCH, Landau AMet al., 2022, Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs, NEUROTOXICOLOGY, Vol: 91, Pages: 166-176, ISSN: 0161-813X

Journal article

Horsager J, Okkels N, Van Den Berge N, Jacobsen J, Schact A, Munk OL, Vang K, Bender D, Brooks DJ, Borghammer Pet al., 2022, In vivo vesicular acetylcholine transporter density in human peripheral organs: an [F-18] FEOBV PET/CT study, EJNMMI RESEARCH, Vol: 12, ISSN: 2191-219X

Journal article

Sigurdsson HP, Yarnall AJ, Galna B, Lord S, Alcock L, Lawson RA, Colloby SJ, Firbank MJ, Taylor J-P, Pavese N, Brooks DJ, O'Brien JT, Burn DJ, Rochester Let al., 2022, Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease, MOVEMENT DISORDERS, Vol: 37, Pages: 1222-1234, ISSN: 0885-3185

Journal article

Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJet al., 2022, Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum, JAMA NEUROLOGY, Vol: 79, Pages: 228-243, ISSN: 2168-6149

Journal article

Horsager J, Okkels N, Hansen AK, Damholdt MF, Andersen KH, Fedorova TD, Munk OL, Danielsen EH, Pavese N, Brooks DJ, Borghammer Pet al., 2022, Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [F-18]FEOBV PET Case-Control Study, JOURNAL OF PARKINSONS DISEASE, Vol: 12, Pages: 2493-2506, ISSN: 1877-7171

Journal article

Madsen LS, Nielsen RB, Parbo P, Ismail R, Mikkelsen IK, Gottrup H, Ƙstergaard L, Brooks DJ, Eskildsen SFet al., 2022, Capillary function progressively deteriorates in prodromal Alzheimer’s disease: A longitudinal MRI perfusion study, Aging Brain, Vol: 2, Pages: 100035-100035, ISSN: 2589-9589

Journal article

Kjeldsen PL, Parbo P, Hansen KV, Aanerud JFA, Ismail R, Nissen PH, Dalby RB, Damholdt MF, Borghammer P, Brooks DJet al., 2022, Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study, Aging Brain, Vol: 2, Pages: 100048-100048, ISSN: 2589-9589

Journal article

Leng F, Hinz R, Gentleman S, Brooks DJ, Edison Pet al., 2021, Neuroinflammation, functional connectivity and structural network integrity in the Alzheimer's spectrum, Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol: 17

BACKGROUND: To investigate whether neuroinflammation and β-amyloid (Aβ) deposition influence brain structural and functional connectivity in Alzheimer's spectrum, we conducted a cross-sectional multimodal imaging study and interrogated the associations between imaging biomarkers of neuroinflammation, Aβ deposition, brain connectivity and cognition. METHOD: 58 participants (25 MCI, 16 AD dementia and 17 healthy controls) were recruited and scanned with 11 C-PBR28 and 18 F-flutemetamol PET, T1-weighted, diffusion tensor and resting-state functional MRI. Brain structural and functional connectivity were assessed by global white matter integrity and functional topology metrics, while neuroinflammation and Aβ deposition were evaluated by 11 C-PBR28 and 18 F-flutemetamol uptake, respectively. Changes of the biomarkers were compared between diagnostic groups and robust regression analyses at both voxel and regional level were performed on Aβ positive patients, who were considered to be representative of Alzheimer's continuum. RESULT: Increased 11 C-PBR28 and 18 F-flutemetamol uptake, decreased FA values, impaired small-worldness and local efficiency of functional network were observed in the AD cohort. In Aβ-positive patients, cortical 11 C-PBR28 uptake correlated with decreased structural integrity and network local efficiency independent of 18 F-flutemetamol uptake and cortical thickness. Network structural integrity and cortical thickness correlated with functional metrics, including small-worldness and local efficiency, which were all associated with cognition. CONCLUSION: Our findings suggest that cortical neuroinflammation may lead to disruption of structural and functional brain network independent of amyloid deposition and cortical atrophy, which in turn can lead to cognitive impairment in AD.

Journal article

Venkataraman A, Bishop C, Mansur A, Rizzo G, Lewis Y, Kocagoncu E, Lingford-Hughes A, Huiban M, Passchier J, Rowe JB, Tsukada H, Brooks DJ, Martarello L, Comley RA, Chen L, Hargreaves R, Schwarz AJ, Gunn RN, Rabiner E, Matthews PMet al., 2021, Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimer’s Disease, Publisher: Cold Spring Harbor Laboratory

Background Synaptic loss and neurite dystrophy are early events in Alzheimer’s Disease (AD). We aimed to characterise early synaptic microstructural changes in vivo.Methods MRI neurite orientation dispersion and density imaging (NODDI) and diffusion tensor imaging (DTI) were used to image cortical microstructure in both sporadic, late onset, amyloid PET positive AD patients and healthy controls (total n = 28). We derived NODDI measures of grey matter extracellular free water (FISO), neurite density (NDI) and orientation dispersion (ODI), which provides an index of neurite branching and orientation, as well as more conventional DTI measures of fractional anisotropy (FA), mean/axial/radial diffusivity (MD, AD, RD, respectively). We also performed [11C]UCB-J PET, which provides a specific measure of the density of pre-synaptic vesicular protein SV2A. Both sets of measures were compared to regional brain volumes.Results The AD patients showed expected relative decreases in regional brain volumes (range, -6 to - 23%) and regional [11C]UCB-J densities (range, -2 to -25%). Differences between AD and controls were greatest in the hippocampus. NODDI microstructural measures showed greater FISO (range, +26 to +44%) in AD, with little difference in NDI (range, -1 to +7%) and mild focal changes in ODI (range, -4 to +3%). Regionally greater FISO and lower [11C]UCB-J binding were correlated across grey matter in patients (most strongly in the caudate, r2 = 0.37, p = 0.001). FISO and DTI RD were strongly positively associated, particularly in the hippocampus (r2 = 0.98, p < 7.4 × 10−9). After 12-18 months we found a 5% increase in FISO in the temporal lobe, but little change across all ROIs in NDI and ODI. An exploratory analysis showed higher parietal lobe FISO was associated with lower language scores in people with AD.Conclusions We interpreted the increased extracellular free water as a possible consequence of glial activation. The dynamic range of disease

Working paper

Doppler CEJ, Kinnerup MB, Brune C, Farrher E, Betts M, Fedorova TD, Schaldemose JL, Knudsen K, Ismail R, Seger AD, Hansen AK, Staer K, Fink GR, Brooks DJ, Nahimi A, Borghammer P, Sommerauer Met al., 2021, Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease, BRAIN, Vol: 144, Pages: 2732-2744, ISSN: 0006-8950

Journal article

Vibholm AK, Dietz MJ, Beniczky S, Christensen J, Hojlund A, Jacobsen J, Bender D, Moller A, Brooks DJet al., 2021, Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [F-18]GE-179 positron emission tomography, EPILEPSIA, Vol: 62, Pages: 2899-2908, ISSN: 0013-9580

Journal article

, 2021, Abstracts of the MDS Virtual Congress 2021., Mov Disord, Vol: 36 Suppl 1, Pages: S1-S599

Journal article

Pasquini J, Brooks DJ, Pavese N, 2021, The Cholinergic Brain in Parkinson's Disease, MOVEMENT DISORDERS CLINICAL PRACTICE, Vol: 8, Pages: 1012-1026, ISSN: 2330-1619

Journal article

Venkataraman A, Mansur A, Rizzo G, Bishop C, Lewis Y, Kocagoncu E, Lingford-Hughes A, Huiban M, Passchier J, Rowe J, Tsukada H, Brooks DJ, Martarello L, Comley RA, Chen L, Schwarz AJ, Hargreaves R, Gunn R, Rabiner E, Matthews PMet al., 2021, Widespread cell stress and mitochondrial dysfunction in early Alzheimer’s Disease, Publisher: MedRxiv

Cell stress and impaired oxidative phosphorylation are central to mechanisms of synaptic loss and neurodegeneration in the cellular pathology of Alzheimer’s disease (AD). We quantified the in vivo density of the endoplasmic reticulum stress marker, the sigma 1 receptor (S1R) using [11C]SA4503 PET, as well as that of mitochondrial complex I (MC1) with [18F]BCPP-EF and the pre-synaptic vesicular protein SV2A with [11C]UCB-J in 12 patients with early AD and in 16 cognitively normal controls. We integrated these molecular measures with assessments of regional brain volumes and brain perfusion (CBF) measured with MRI arterial spin labelling. 8 AD patients were followed longitudinally to estimate rates of change with disease progression over 12-18 months. The AD patients showed widespread increases in S1R (≤ 27%) and regional decreases in MC1 (≥ -28%), SV2A (≥ -25%), brain volume (≥ -23%), and CBF (≥ -26%). [18F]BCPP-EF PET MC1 density (≥ -12%) and brain volumes (≥ -5%) were further reduced at follow up in brain regions consistent with the differences between AD patients and controls at baseline. Exploratory analyses showing associations of MC1, SV2A and S1R density with cognitive changes at baseline and longitudinally with AD, but not in controls, suggested a loss of metabolic functional reserve with disease. Our study thus provides novel in vivo evidence for widespread cellular stress and bioenergetic abnormalities in early AD and that they may be clinically meaningful.

Working paper

Pagano G, Molloy S, Bain PG, Rabiner EA, Chaudhuri KR, Brooks DJ, Pavese Net al., 2021, Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study, PARKINSONISM & RELATED DISORDERS, Vol: 90, Pages: 52-56, ISSN: 1353-8020

Journal article

Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HSet al., 2021, Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease, NPJ PARKINSONS DISEASE, Vol: 7

Journal article

Binda KH, Lillethorup TP, Real CC, Baerentzen SL, Nielsen MN, Orlowski D, Brooks DJ, Chacur M, Landau AMet al., 2021, Exercise protects synaptic density in a rat model of Parkinson's disease, EXPERIMENTAL NEUROLOGY, Vol: 342, ISSN: 0014-4886

Journal article

Andersen KB, Hansen AK, Damholdt MF, Horsager J, Skjaerbaek C, Gottrup H, Klit H, Danielsen EH, Brooks DJ, Borghammer Pet al., 2021, Reduced Synaptic Density in Patients with Lewy Body Dementia: An [C-11]UCB-J PET Imaging Study, MOVEMENT DISORDERS, Vol: 36, Pages: 2057-2065, ISSN: 0885-3185

Journal article

Eskildsen SF, Iranzo A, Stokholm MG, Staer K, Ostergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Moller A, Gaig C, Brooks DJ, Tolosa E, Ostergaard L, Pavese Net al., 2021, Impaired cerebral microcirculation in isolated REM sleep behaviour disorder, BRAIN, Vol: 144, Pages: 1498-1508, ISSN: 0006-8950

Journal article

Brooks DJ, 2021, Future Imaging in Dementia, SEMINARS IN NUCLEAR MEDICINE, Vol: 51, Pages: 303-308, ISSN: 0001-2998

Journal article

Farmen K, Nissen SK, Stokholm MG, Iranzo A, Ostergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Moller A, Gaig C, Brooks DJ, Tolosa E, Pavese N, Romero-Ramos Met al., 2021, Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Vol: 118, ISSN: 0027-8424

Journal article

Kinnerup MB, Sommerauer M, Damholdt MF, Schaldemose JL, Ismail R, Terkelsen AJ, Staer K, Hansen A, Fedorova TD, Knudsen K, Skjaerbaek C, Borghammer P, Pavese N, Brooks DJ, Nahimi Aet al., 2021, Preserved noradrenergic function in Parkinson's disease patients with rest tremor, NEUROBIOLOGY OF DISEASE, Vol: 152, ISSN: 0969-9961

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: respub-action=search.html&id=00163134&limit=30&person=true